Incidence of and risk factors for severe acute kidney injury in children with heart failure treated with renin–angiotensin system inhibitors

Chikako Terano(National Center For Child Health and Development), Masataka Honda(Rikkyo University), Yuko Hamasaki(Toho University), Tomoyuki Sakai(Tokyo Metropolitan Children's Medical Center), Hiroshi Hataya(Japanese Society for Dialysis Therapy), Kenji Ishikura(Kitasato University), Takashi Ando(Japan Clinical Cancer Research Organization), Masaru Miura(Tokyo Metropolitan Children's Medical Center), Ryoko Harada(Tokyo Metropolitan Children's Medical Center), Riku Hamada
European Journal of Pediatrics
December 21, 2015
10.1007/s00431-015-2680-8
Cited by 15

Related Papers

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial
|The Lancet|2014|450
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|278
Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease
|Clinical and Experimental Nephrology|2013|267
Epidemiology of pediatric chronic kidney disease/kidney failure: learning from registries and cohort studies
|Pediatric Nephrology|2021|149
A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment
|Kidney International|2014|135